(4S,6E)-4-hydroxy-3-methyl-6-(6-methylhept-5-en-2-ylidene)cyclohex-2-en-1-one

Details

Top
Internal ID cdad0be8-4f56-470c-b8f5-a5e6fd3b791d
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids
IUPAC Name (4S,6E)-4-hydroxy-3-methyl-6-(6-methylhept-5-en-2-ylidene)cyclohex-2-en-1-one
SMILES (Canonical) CC1=CC(=O)C(=C(C)CCC=C(C)C)CC1O
SMILES (Isomeric) CC1=CC(=O)/C(=C(\C)/CCC=C(C)C)/C[C@@H]1O
InChI InChI=1S/C15H22O2/c1-10(2)6-5-7-11(3)13-9-14(16)12(4)8-15(13)17/h6,8,14,16H,5,7,9H2,1-4H3/b13-11+/t14-/m0/s1
InChI Key XYLPDPPGAMCDQW-CMPYXILNSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H22O2
Molecular Weight 234.33 g/mol
Exact Mass 234.161979940 g/mol
Topological Polar Surface Area (TPSA) 37.30 Ų
XlogP 3.00
Atomic LogP (AlogP) 3.33
H-Bond Acceptor 2
H-Bond Donor 1
Rotatable Bonds 3

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (4S,6E)-4-hydroxy-3-methyl-6-(6-methylhept-5-en-2-ylidene)cyclohex-2-en-1-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 1.0000 100.00%
Caco-2 + 0.8291 82.91%
Blood Brain Barrier + 0.7750 77.50%
Human oral bioavailability + 0.5286 52.86%
Subcellular localzation Mitochondria 0.7593 75.93%
OATP2B1 inhibitior - 0.8552 85.52%
OATP1B1 inhibitior + 0.9388 93.88%
OATP1B3 inhibitior + 0.9466 94.66%
MATE1 inhibitior - 0.8600 86.00%
OCT2 inhibitior - 0.6250 62.50%
BSEP inhibitior - 0.7202 72.02%
P-glycoprotein inhibitior - 0.9654 96.54%
P-glycoprotein substrate - 0.8480 84.80%
CYP3A4 substrate - 0.5345 53.45%
CYP2C9 substrate - 0.5963 59.63%
CYP2D6 substrate - 0.8503 85.03%
CYP3A4 inhibition - 0.7851 78.51%
CYP2C9 inhibition - 0.9318 93.18%
CYP2C19 inhibition - 0.9114 91.14%
CYP2D6 inhibition - 0.9136 91.36%
CYP1A2 inhibition - 0.7966 79.66%
CYP2C8 inhibition - 0.9505 95.05%
CYP inhibitory promiscuity - 0.8839 88.39%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.8028 80.28%
Carcinogenicity (trinary) Non-required 0.7099 70.99%
Eye corrosion - 0.9481 94.81%
Eye irritation + 0.5854 58.54%
Skin irritation + 0.6611 66.11%
Skin corrosion - 0.9718 97.18%
Ames mutagenesis - 0.6300 63.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5807 58.07%
Micronuclear - 0.9900 99.00%
Hepatotoxicity + 0.5803 58.03%
skin sensitisation + 0.8604 86.04%
Respiratory toxicity + 0.5222 52.22%
Reproductive toxicity - 0.5444 54.44%
Mitochondrial toxicity - 0.8000 80.00%
Nephrotoxicity - 0.5515 55.15%
Acute Oral Toxicity (c) III 0.7425 74.25%
Estrogen receptor binding - 0.7092 70.92%
Androgen receptor binding - 0.7892 78.92%
Thyroid receptor binding - 0.7274 72.74%
Glucocorticoid receptor binding + 0.6167 61.67%
Aromatase binding - 0.8772 87.72%
PPAR gamma + 0.6085 60.85%
Honey bee toxicity - 0.9000 90.00%
Biodegradation - 0.7000 70.00%
Crustacea aquatic toxicity - 0.5900 59.00%
Fish aquatic toxicity + 0.9625 96.25%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 95.48% 98.95%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 91.14% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 90.47% 95.56%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 85.39% 96.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 85.33% 100.00%
CHEMBL1293267 Q9HC97 G-protein coupled receptor 35 81.50% 89.34%
CHEMBL3401 O75469 Pregnane X receptor 81.35% 94.73%

Cross-Links

Top
PubChem 10059937
NPASS NPC228354
LOTUS LTS0020022
wikiData Q105344550